1. Home
  2. LGND vs CWK Comparison

LGND vs CWK Comparison

Compare LGND & CWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CWK
  • Stock Information
  • Founded
  • LGND 1987
  • CWK 1784
  • Country
  • LGND United States
  • CWK United States
  • Employees
  • LGND N/A
  • CWK N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CWK Real Estate
  • Sector
  • LGND Health Care
  • CWK Finance
  • Exchange
  • LGND Nasdaq
  • CWK Nasdaq
  • Market Cap
  • LGND 2.0B
  • CWK 1.9B
  • IPO Year
  • LGND 1992
  • CWK 2018
  • Fundamental
  • Price
  • LGND $102.19
  • CWK $10.02
  • Analyst Decision
  • LGND Strong Buy
  • CWK Hold
  • Analyst Count
  • LGND 8
  • CWK 7
  • Target Price
  • LGND $144.71
  • CWK $12.93
  • AVG Volume (30 Days)
  • LGND 118.3K
  • CWK 1.7M
  • Earning Date
  • LGND 05-08-2025
  • CWK 04-29-2025
  • Dividend Yield
  • LGND N/A
  • CWK N/A
  • EPS Growth
  • LGND N/A
  • CWK 1337.16
  • EPS
  • LGND N/A
  • CWK 0.69
  • Revenue
  • LGND $181,488,000.00
  • CWK $9,546,300,000.00
  • Revenue This Year
  • LGND $17.68
  • CWK $5.23
  • Revenue Next Year
  • LGND $18.69
  • CWK $6.00
  • P/E Ratio
  • LGND N/A
  • CWK $14.45
  • Revenue Growth
  • LGND 53.40
  • CWK 1.24
  • 52 Week Low
  • LGND $77.43
  • CWK $7.64
  • 52 Week High
  • LGND $129.90
  • CWK $16.11
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • CWK 51.75
  • Support Level
  • LGND $98.90
  • CWK $10.20
  • Resistance Level
  • LGND $103.17
  • CWK $10.09
  • Average True Range (ATR)
  • LGND 3.05
  • CWK 0.26
  • MACD
  • LGND -0.27
  • CWK -0.04
  • Stochastic Oscillator
  • LGND 31.94
  • CWK 35.76

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CWK Cushman & Wakefield plc

Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.

Share on Social Networks: